Orthofix Medical Inc. OFIX
Set alert
8.68 USD -0.07 -0.80%
As of Nov 3, 9:32 AM ET
8.55 Day range 8.72
8.50 52-week range 16.99
- YTD
- -42.74%
- 1 year
- -43.78%
- Open
- 8.72
- Prev close
- 8.75
- Mkt cap
- 348.26M
- Vol
- 7.12K
- Avg vol
- 390.38K
- EPS
- -1.52
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 8.55
- High
- 8.72
- Forward P/E
- -1733.00
- Beta
- 1.05
- Short ratio
- 3.89
- Inst. own
- 92.27%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 17.72
- 200-d avg
- 15.53
- 1y target
- 24.40
1M chart
Signals (9)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Nov 2, 2026 | 1 day ago |
| SMA: Bearish | Oct 30, 2026 | 4 days ago |
| SMA: Bearish | Oct 30, 2026 | 4 days ago |
| SMA: Bullish | Oct 19, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 16, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 15, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 13, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 7, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 4 weeks ago |
Analyst view
Consensus: none
Price target (mean) 24.40 +181.1% upside
Now 8.68
- Target (low)
- 22.00
- Target (mean)
- 24.40
- Target (high)
- 27.20
Ratings (0m) 5 3 buy · 2 hold · 0 sell
- Strong buy1
- Buy2
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.05 | -0.12 – 0.08 | 0.0281 | -277.9% | 212.83M | +6.2% | 3 |
| Next quarter | -0.05 | -0.09 – -0.01 | -0.1912 | +73.9% | 199.41M | +5.7% | 2 |
| Current year | -0.12667 | -0.14 – -0.11 | -0.4939 | +74.4% | 796.61M | +6.7% | 3 |
| Next year | -0.03 | -0.12 – 0.02 | -0.12667 | +76.3% | 846.93M | +6.3% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 8, 2024 | Roth MKM | Reiterated | Buy | Buy |
| Nov 8, 2024 | Stifel | Upgrade | Hold | Buy |
| May 8, 2024 | Roth MKM | Upgrade | Neutral | Buy |
| Apr 22, 2024 | JMP Securities | Reiterated | — | Market Perform |
| Mar 7, 2024 | Roth MKM | Maintained | Neutral | Neutral |
| Oct 20, 2023 | Roth MKM | Initiated | — | Neutral |
| Sep 12, 2023 | BTIG | Downgrade | Buy | Neutral |
| Sep 12, 2023 | Stifel | Downgrade | Buy | Hold |
| Mar 4, 2022 | Stifel | Upgrade | Hold | Buy |
| Oct 20, 2020 | Stifel | Initiated | — | Hold |
| Feb 25, 2020 | Sidoti & Co. | Maintained | — | Buy |
| Feb 25, 2020 | Cantor Fitzgerald | Maintained | — | Neutral |
| Oct 29, 2019 | Cantor Fitzgerald | Downgrade | Overweight | Neutral |
| Feb 26, 2019 | BTIG | Downgrade | Buy | Neutral |
| Jun 1, 2018 | Cantor Fitzgerald | Initiated | — | Overweight |
| Jun 21, 2017 | BTIG | Initiated | — | Buy |
| Jun 14, 2017 | Ladenburg Thalmann | Initiated | — | Buy |
| May 23, 2017 | SunTrust Robinson Humphrey | Initiated | — | Buy |
| May 9, 2013 | JMP Securities | Downgrade | Market Outperform | Market Perform |
| May 9, 2013 | Mizuho | Downgrade | Buy | Neutral |
| May 9, 2013 | Janney Montgomery Scott | Downgrade | Buy | Neutral |
| May 9, 2013 | Lazard | Downgrade | Buy | Sell |
| Feb 25, 2013 | Piper Sandler | Maintained | — | Neutral |
| Jan 3, 2013 | Lazard | Maintained | — | Buy |
| Oct 31, 2012 | Piper Sandler | Maintained | — | Neutral |